《Table 2–The preparation and characteristics of novel carrier-free based nano-drug delivery systems

《Table 2–The preparation and characteristics of novel carrier-free based nano-drug delivery systems   提示:宽带有限、当前游客访问压缩模式
本系列图表出处文件名:随高清版一同展现
《Evolution from small molecule to nano-drug delivery systems:An emerging approach for cancer therapy of ursolic acid》


  1. 获取 高清版本忘记账户?点击这里登录
  1. 下载图表忘记账户?点击这里登录

Mesoporous silica nanoparticles(MSNs)is a promising drug delivery system due to its high surface area,narrow pore size distribution,superior chemical property,mechanical stability,and facile surface functionalization[79–83].UA-loaded MSNs(UA@MSN-UA) with particle size of 100 nm displayed a higher cytotoxic effect against Hep G2 cells than free UA[66].The nanoparticles released 76%of the loaded UA in 96 h at p H 5.5,whereas 53%was released at p H 7.4,indicating its sustained and p H-responsive release properties.In another study,our group developed active targeting ligand FA and chitosan comodified UA-loaded MSNs(UA@M-CS-FA)and evaluated the targeted delivery efficiency of UA to FA-receptor positive cancer cells[67].Mechanistically,UA@M-CS-FA exhibited remarkable inhibition on the migration of cancer cells through regulating P53/MMP-9/PTEN/CD44 proteins.Also,in vivo experiments revealed that UA@M-CS-FA significantly inhibited the tumor proliferation and migration[67].Similarly,another mesoporous silica nanocarrier(MSN-CS-LA)modified with p H-responsive chitosan and LA was developed for codelivering UA and sorafenib.This nanoparticle could improve the cellular uptake and internalization of drugs against ASGPR over-expressing cell lines[68].In conclusion,the development of multifunctional MSNs provides a new way for efficiently delivering UA into tumor tissues.